Wenliang Wang

854 total citations
23 papers, 646 citations indexed

About

Wenliang Wang is a scholar working on Molecular Biology, Pharmacology and Epidemiology. According to data from OpenAlex, Wenliang Wang has authored 23 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pharmacology and 6 papers in Epidemiology. Recurrent topics in Wenliang Wang's work include Microbial Natural Products and Biosynthesis (7 papers), Genomics and Phylogenetic Studies (3 papers) and Hepatitis B Virus Studies (3 papers). Wenliang Wang is often cited by papers focused on Microbial Natural Products and Biosynthesis (7 papers), Genomics and Phylogenetic Studies (3 papers) and Hepatitis B Virus Studies (3 papers). Wenliang Wang collaborates with scholars based in China, Canada and United States. Wenliang Wang's co-authors include Thomas London, Mark A. Feitelson, Laura Lega, Gerard D. Wright, Tianjiao Zhu, Min Zhang, Weiming Zhu, Qianqun Gu, Yuchun Fang and Nicholas Waglechner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Wenliang Wang

21 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenliang Wang China 12 314 208 110 99 73 23 646
Ruilin Sun China 15 186 0.6× 124 0.6× 76 0.7× 10 0.1× 47 0.6× 26 492
So‐Yeon Park South Korea 16 293 0.9× 132 0.6× 36 0.3× 30 0.3× 118 1.6× 75 802
Yufeng Liu China 10 153 0.5× 87 0.4× 57 0.5× 30 0.3× 30 0.4× 48 554
Xiaojuan Wang China 15 290 0.9× 112 0.5× 26 0.2× 59 0.6× 44 0.6× 43 693
Swati Mandal India 11 388 1.2× 67 0.3× 130 1.2× 22 0.2× 16 0.2× 14 603
Katja Gemperlein Germany 16 409 1.3× 98 0.5× 92 0.8× 64 0.6× 6 0.1× 18 599
Ching-Yao Chang Taiwan 13 180 0.6× 57 0.3× 183 1.7× 8 0.1× 41 0.6× 15 655
Fengqin Dong China 18 548 1.7× 23 0.1× 92 0.8× 33 0.3× 135 1.8× 50 921
Yiwen Hu China 9 164 0.5× 128 0.6× 30 0.3× 121 1.2× 19 0.3× 14 488
Dirk Schröder Germany 12 204 0.6× 41 0.2× 116 1.1× 43 0.4× 42 0.6× 31 517

Countries citing papers authored by Wenliang Wang

Since Specialization
Citations

This map shows the geographic impact of Wenliang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenliang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenliang Wang more than expected).

Fields of papers citing papers by Wenliang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenliang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenliang Wang. The network helps show where Wenliang Wang may publish in the future.

Co-authorship network of co-authors of Wenliang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenliang Wang. A scholar is included among the top collaborators of Wenliang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenliang Wang. Wenliang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Bixia, Xinan Sheng, Shusuan Jiang, et al.. (2025). Nectin-4 targeted ADC, SHR-A2102, in patients with advanced or metastatic urothelial carcinoma: A phase 1 study.. Journal of Clinical Oncology. 43(5_suppl). 657–657. 2 indexed citations
2.
4.
Zhou, Hongliang, Jikang Liu, Yuqing Wu, et al.. (2024). Unveiling the interoception impairment in various major depressive disorder stages. CNS Neuroscience & Therapeutics. 30(8). e14923–e14923. 6 indexed citations
5.
Cook, Michael A., Linda Ejim, Xiaodong Wang, et al.. (2023). Lessons from assembling a microbial natural product and pre-fractionated extract library in an academic laboratory. Journal of Industrial Microbiology & Biotechnology. 50(1). 8 indexed citations
6.
Xu, Min, et al.. (2022). Phylogeny-Informed Synthetic Biology Reveals Unprecedented Structural Novelty in Type V Glycopeptide Antibiotics. ACS Central Science. 8(5). 615–626. 17 indexed citations
7.
Ma, Xiu‐Juan, et al.. (2021). Protective Effect of Buyang Huanwu Decoction on Cerebral Ischemia Reperfusion Injury by Alleviating Autophagy in the Ischemic Penumbra. Evidence-based Complementary and Alternative Medicine. 2021. 1–13. 11 indexed citations
8.
Zhang, Zhiming, Di Liu, Rui Zhang, Junqi Li, & Wenliang Wang. (2021). The impact of rainfall change on rainwater source control in Beijing. Urban Climate. 37. 100841–100841. 10 indexed citations
9.
Xu, Min, et al.. (2020). GPAHex-A synthetic biology platform for Type IV–V glycopeptide antibiotic production and discovery. Nature Communications. 11(1). 5232–5232. 28 indexed citations
11.
Culp, Elizabeth, Grace Yim, Nicholas Waglechner, et al.. (2019). Hidden antibiotics in actinomycetes can be identified by inactivation of gene clusters for common antibiotics. Nature Biotechnology. 37(10). 1149–1154. 67 indexed citations
12.
Yim, Grace, Wenliang Wang, A Pawłowski, & Gerard D. Wright. (2018). Trichlorination of a Teicoplanin-Type Glycopeptide Antibiotic by the Halogenase StaI Evades Resistance. Antimicrobial Agents and Chemotherapy. 62(12). 2 indexed citations
13.
Robbins, Nicole, Michaela Spitzer, Wenliang Wang, et al.. (2016). Discovery of Ibomycin, a Complex Macrolactone that Exerts Antifungal Activity by Impeding Endocytic Trafficking and Membrane Function. Cell chemical biology. 23(11). 1383–1394. 30 indexed citations
14.
Qiao, Qing, Jing Zhang, Wenliang Wang, & Qing Li. (2008). Over expression of transforming growth factor-alpha and epidermal growth factor receptor in human hepatic cirrhosis tissues.. PubMed. 55(81). 169–72. 9 indexed citations
15.
Zhang, Min, Wenliang Wang, Yuchun Fang, et al.. (2008). Cytotoxic Alkaloids and Antibiotic Nordammarane Triterpenoids from the Marine-Derived Fungus Aspergillus sydowi. Journal of Natural Products. 71(6). 985–989. 129 indexed citations
16.
Wang, Li, et al.. (2007). Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma. Hepatology Research. 37(5). 389–396. 95 indexed citations
17.
Li, Jiang, et al.. (2000). Inducible overexpression of Bak sensitizes HCC-9204 cells to apoptosis induced by doxorubicin.. PubMed. 21(9). 769–76. 6 indexed citations
18.
19.
Guo, Shuangping & Wenliang Wang. (1999). Expression of HBVx gene in hepatocellular carcinoma cell and the effect on apoptosis. Experimental Pathology. 15(4). 283–286. 1 indexed citations
20.
Wang, Wenliang, Thomas London, Laura Lega, & Mark A. Feitelson. (1991). HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology. 14(1). 29–37. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026